For this reason it is effective in treatment of certain bleeding disorders, and it is sold under the brand name Amicar.

[3] Aminocaproic acid is also an intermediate in the polymerization of Nylon-6, where it is formed by ring-opening hydrolysis of caprolactam.

The crystal structure determination showed that the 6-aminohexanoic acid is present as a salt, at least in the solid state.

[4] Aminocaproic acid (Amicar) is FDA-approved for use in the treatment of acute bleeding due to elevated fibrinolytic activity.

[3] It also carries an orphan drug designation from the FDA for the prevention of recurrent hemorrhage in patients with traumatic hyphema.